Published in Curr Psychiatry Rep on October 01, 2012
Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry (2014) 1.58
What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry (2013) 1.15
Combination and switching of stimulants in children and adolescents with attention deficit/hyperactivity disorder in quebec. J Can Acad Child Adolesc Psychiatry (2014) 1.14
Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. J Am Acad Child Adolesc Psychiatry (2016) 0.83
Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2015) 0.77
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother (2007) 2.99
Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm (2008) 2.64
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm (2003) 1.69
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications. Arch Pediatr Adolesc Med (2011) 1.68
Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm (2005) 1.48
Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation. Am J Health Syst Pharm (2008) 1.41
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis. Value Health (2010) 1.39
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.05
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg (2009) 0.97
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida. J Pediatr (2010) 0.94
An in-depth analysis of medication errors in hospitalized patients with HIV. Ann Pharmacother (2011) 0.92
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion. Ann Pharmacother (2011) 0.91
An algorithm to identify preterm infants in administrative claims data. Pharmacoepidemiol Drug Saf (2012) 0.89
Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling. J Am Pharm Assoc (2003) (2011) 0.86
Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother (2007) 0.85
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Pharmacotherapy (2006) 0.85
Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study. J Am Heart Assoc (2013) 0.83
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiol Drug Saf (2010) 0.82
Automated medication error studies with audit supplementation were effectively designed and analyzed by time series. J Clin Epidemiol (2006) 0.81
Planning for pharmacy health information technology in critical access hospitals. Am J Health Syst Pharm (2007) 0.81
Projecting the effect of nesiritide on dialysis and hospital mortality in cardiac surgery patients. Value Health (2010) 0.80
An evaluation of the effects of gatifloxacin on glucose homeostasis. Pharm World Sci (2008) 0.79
Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiol Drug Saf (2015) 0.78
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. BMC Med Res Methodol (2012) 0.78
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis (2013) 0.77
Anti-diabetic drug utilization of pregnant diabetic women in us managed care. BMC Pregnancy Childbirth (2014) 0.76
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin (2014) 0.76
Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly. Ann Pharmacother (2008) 0.76
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol (2006) 0.76
RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf (2014) 0.75
Response to respiratory synctial virus. South Med J (2008) 0.75
Intensive glucose lowering and cardiovascular outcomes. N Engl J Med (2011) 0.75
Response to Letter to the editor regarding Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes. Otolaryngol Head Neck Surg (2013) 0.75
Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study. Otol Neurotol (2010) 0.75
Perioperative medication errors in otolaryngology. Laryngoscope (2010) 0.75
Negative Results Do Not Imply Absence of Ototoxicity with Middle Ear Application of Neomycin. Otolaryngol Head Neck Surg (2014) 0.75
A tool kit for practice-based research. Am J Health Syst Pharm (2008) 0.75
Epidemiology of Persistent Tympanic Membrane Perforations Subsequent to Tympanostomy Tubes Assessed With Real World Data. Otol Neurotol (2016) 0.75
Consistency of psychotropic drug-drug interactions listed in drug monographs. J Am Pharm Assoc (2003) (2017) 0.75
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply. Arch Pediatr Adolesc Med (2012) 0.75
Development of a Medication Safety and Quality Survey for Small Rural Hospitals. J Patient Saf (2017) 0.75